Inhibition of VEGF165/VEGFR2-dependent signaling by LECT2 suppresses hepatocellular carcinoma angiogenesis-Reference-Cited by-同舟云学术

Inhibition of VEGF165/VEGFR2-dependent signaling by LECT2 suppresses hepatocellular carcinoma angiogenesis

Published:2016-08 Issue:1 Volume:6 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Chen Chi-Kuan,Yu Wen-Hsuan,Cheng Tsu-Yao,Chen Min-Wei,Su Chia-Yi,Yang Yi-Chieh,Kuo Tsang-Chih,Lin Ming-Tsan,Huang Ya-Chi,Hsiao Michael,Hua Kuo-Tai,Hung Mien-Chie,Kuo Min-Liang

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep31398.pdf

Reference45 articles.

1. Zhu, A. X., Duda, D. G., Sahani, D. V. & Jain, R. K. HCC and angiogenesis: possible targets and future directions. Nature reviews. Clinical oncology 8, 292–301, doi: 10.1038/nrclinonc.2011.30 (2011).

2. Bupathi, M., Kaseb, A., Meric-Bernstam, F. & Naing, A. Hepatocellular carcinoma: Where there is unmet need. Molecular oncology 9, 9, doi: 10.1016/j.molonc.2015.06.005 (2015).

3. Muto, J., Shirabe, K., Sugimachi, K. & Maehara, Y. Review of angiogenesis in hepatocellular carcinoma. Hepatology research: the official journal of the Japan Society of Hepatology 45, 1–9, doi: 10.1111/hepr.12310 (2015).

4. Carmeliet, P. & Jain, R. K. Molecular mechanisms and clinical applications of angiogenesis. Nature 473, 298–307, doi: 10.1038/nature10144 (2011).

5. Scartozzi, M. et al. VEGF and VEGFR genotyping in the prediction of clinical outcome for HCC patients receiving sorafenib: the ALICE-1 study. International journal of cancer. Journal international du cancer 135, 1247–1256, doi: 10.1002/ijc.28772 (2014).

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Updates on the role of leukocyte cell-derived chemotaxin-2 in inflammation regulation and immunomodulation;Cytokine;2024-09

2. Global research trends and hotspots for leukocyte cell-derived chemotaxin-2 from the past to 2023: a combined bibliometric review;Frontiers in Immunology;2024-05-31

3. Loss of LECT2 promotes ovarian cancer progression by inducing cancer invasiveness and facilitating an immunosuppressive environment;Oncogene;2024-01-04

4. Identification of a immune-related gene signature as a novel prognostic biomarker of cholangiocarcinoma;2023-08-17

5. Unveiling the antitumor potential of novel N-(substituted-phenyl)-8-methoxycoumarin-3-carboxamides as dual inhibitors of VEGFR2 kinase and cytochrome P450 for targeted treatment of hepatocellular carcinoma;Frontiers in Chemistry;2023-08-04